Bibliografia essenziale

  1. Matsuda H, Kawakami Y, Furuya K, Kikuchi Y. Intrauterine therapy for a cytomegalovirus-infected symptomatic fetus. Br J Obstet Gynaecol 2004;111:756-7 –
  2. Negishi H, Yamada H, Hirayama E, Okuyama K, Sagawa T, Matsumoto Y, Fujimoto S. Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus. J Perinatol 1998;18:466-9 –
  3. Nigro G, La Torre R, Anceschi MM, Mazzocco M, Cosmi EV.Hyperimmunoglobulin therapy for a twin fetus with cytomegalovirus infection and growth restriction. Am J Obstet Gynecol 1999;180:1222-6 –
  4. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350-6 –
  5. Adler S, Nigro G. Progress towards interrupting intrauterine transmission of cytomegalovirus? Rev Med Virol 2006;16:69-71 –
  6. La Torre R, Nigro G, Mazzocco M , Best AM, Adler SP. Placental enlargement in women with a primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 2006;43:994-1000. –
  7. Adler S, Nigro G, Pereira L. Recent advances in the prevention and treatment of cytomegalovirus infections. Semin Perinatol 2007;31:10-8 –
  8. Moxley K, Knudtson E. Resolution of hydrops secondary to cytomegalovirus infection after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol 2008;111:524-6 –
  9. Nigro G, La Torre R,  Pentimalli H, Taverna P, Lituania M, Martinez de Tejada B, Adler SP. Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy. Prenat Diagn 2008;28:512-7 –
  10. Adler SP, Nigro G. The importance of CMV specific antibodies for the prevention of fetal CMV infection. Herpes Journal 2008;15:24-7. –
  11. Nigro G. Maternal-fetal cytomegalovirus infection: from diagnosis to therapy. J Mat Fet Neon Med 2009;22:169–174. –
  12. Patrick Duf, A thoughtful algorithm for the accurate diagnosis of primary CMV infection in pregnancy. AJOG march 2007;196-7 –
  13. S.E. Oliver et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. Journal of Clinical Virology 46S (2009) S22–S26 –
  14. S.P. Adler, G. Nigro. Findings and conclusions from CMV hyperimmune globulin treatment trials. Journal of Clinical Virology 46S (2009) S54–S57 –
  15. N. Nozawa et al. Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream. Journal of Clinical Virology 46S (2009) S58–S63 –